Tectonic Therapeutic, Inc. financial data

Symbol
AVRO on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
490 Arsenal Way, Suite 210, Watertown, Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
Former names
AvroBio, Inc. (to 6/18/2024), AVROBIO, Inc. (to 6/18/2024)
Latest financial report
Q1 2024 - May 9, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.48 K % +87.2%
Debt-to-equity 7.18 % -79%
Return On Equity 29.7 %
Return On Assets 27.7 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 44.9 M shares +1.75%
Common Stock, Shares, Outstanding 44.9 M shares +1.8%
Entity Public Float 36.6 M USD -99.9%
Common Stock, Value, Issued 4 K USD 0%
Weighted Average Number of Shares Outstanding, Basic 44.8 M shares +1.71%
Weighted Average Number of Shares Outstanding, Diluted 44.8 M shares +1.71%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 31.1 M USD -55.8%
General and Administrative Expense 23.3 M USD -24.6%
Costs and Expenses 1.81 M USD -47.6%
Operating Income (Loss) 27.5 M USD +68.5%
Nonoperating Income (Expense) 3.21 M USD +1347%
Net Income (Loss) Attributable to Parent 30.3 M USD +72.7%
Earnings Per Share, Basic 0.69 USD/shares +73.7%
Earnings Per Share, Diluted 0.69 USD/shares +73.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 90.5 M USD +25.1%
Other Assets, Current 626 K USD -25.9%
Assets, Current 91.8 M USD +18.9%
Property, Plant and Equipment, Net 0 USD -100%
Operating Lease, Right-of-Use Asset 110 K USD -96.2%
Other Assets, Noncurrent 0 USD -100%
Assets 92.3 M USD +11.3%
Accounts Payable, Current 243 K USD -58.9%
Employee-related Liabilities, Current 686 K USD -69.8%
Accrued Liabilities, Current 3.04 M USD -72.5%
Liabilities, Current 3.51 M USD -75.5%
Deferred Income Tax Liabilities, Net 0 USD
Operating Lease, Liability, Noncurrent 0 USD -100%
Liabilities 3.51 M USD -88.3%
Retained Earnings (Accumulated Deficit) -484 M USD +5.89%
Stockholders' Equity Attributable to Parent 88.8 M USD +67.6%
Liabilities and Equity 92.3 M USD +11.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -7.57 M USD +62.7%
Net Cash Provided by (Used in) Financing Activities 55 K USD -61.3%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 150 M shares 0%
Common Stock, Shares, Issued 44.9 M shares +1.8%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -7.54 M USD +62.7%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 91.2 M USD +25.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 119 M USD -4.84%
Deferred Tax Assets, Gross 119 M USD -4.99%
Operating Lease, Liability 224 K USD -92.5%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -119 M USD +3.63%
Lessee, Operating Lease, Liability, to be Paid 224 K USD
Property, Plant and Equipment, Gross 6.71 M USD +0.12%
Operating Lease, Liability, Current 224 K USD -91.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year One 0 USD
Operating Lease, Weighted Average Discount Rate, Percent 0.16 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 0 USD
Deferred Tax Assets, Operating Loss Carryforwards 80.2 M USD -12.3%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10 M shares 0%
Preferred Stock, Shares Outstanding 0 shares
Operating Leases, Future Minimum Payments, Due in Two Years 69 K USD
Depreciation, Depletion and Amortization 0 USD -100%
Operating Leases, Future Minimum Payments Due, Next Twelve Months 1.03 M USD
Deferred Tax Assets, Net of Valuation Allowance 118 K USD -63.1%
Share-based Payment Arrangement, Expense 5.24 M USD -50.9%
Operating Leases, Future Minimum Payments, Due in Three Years 0 USD
Operating Leases, Future Minimum Payments Due 1.81 M USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares